This inventor holds 2 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Peking University, Edigene Therapeutics (Beijing) Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: The Innovative Contributions of Inventor Chunhui Wang
Introduction: Chunhui Wang, an accomplished inventor based in Beijing, China, has made significant strides in the field of RNA editing. With two patents to his name, he is recognized for his pioneering methods that have the potential to revolutionize genetic research and therapeutic applications.
Latest Patents: Chunhui Wang's latest patents include "Methods and Compositions for Editing RNAs" and "Targeted RNA Editing by Leveraging Endogenous ADAR Using Engineered RNAs." The first patent focuses on methods for editing RNA by introducing a deaminase-recruiting RNA into host cells to facilitate the deamination of adenine in a target RNA. The second patent also revolves around similar concepts, providing detailed methodologies, compositions, and kits that utilize deaminase-recruiting RNAs for effective RNA editing.
Career Highlights: Chunhui Wang has been associated with notable institutions such as Peking University and Edigene Therapeutics, where he has contributed to advancing genetic research through innovative approaches. His expertise in RNA technologies has positioned him as a valuable asset in these organizations, making significant contributions to their research initiatives.
Collaborations: Throughout his career, Chunhui Wang has collaborated with esteemed colleagues, including Wensheng Wei and Zongyi Yi. These partnerships have fostered a dynamic research environment, paving the way for groundbreaking discoveries in RNA editing techniques.
Conclusion: Chunhui Wang's contributions to RNA editing highlight the importance of innovation in the field of genetics. With his patents reflecting a commitment to advancing scientific understanding, he stands out as a leading inventor in a rapidly evolving domain. His work not only enhances our knowledge of RNA functionalities but also opens doors for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile